{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:19:18Z","timestamp":1791955158168,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.06.031","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T10:34:35Z","timestamp":1529577275000},"page":"4681-4686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates"],"prefix":"10.1016","volume":"36","author":[{"given":"Luciana Gomes Pedro","family":"Brand\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Santoro-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silas de Souza","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson Elias","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Emmanuel Alvarenga Americano","family":"do Brasil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.031_b0005","unstructured":"CDC. Poliomyelitis. Epidemiol. Vaccine Prev. Dis. 13th ed., Washington D.C.; 2015. p. 297\u2013310."},{"key":"10.1016\/j.vaccine.2018.06.031_b0010","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.06.031_b0015","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/aje\/kwr399","article-title":"The probability of undetected wild poliovirus circulation after apparent global interruption of transmission","volume":"175","author":"Kalkowska","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.06.031_b0020","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2018.06.031_b0025","unstructured":"WHO. Poliomyelitis 2017. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs114\/en\/> [accessed March 19, 2018]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0030","unstructured":"GPEI. Global eradication of wild poliovirus type 2 declared; n.d. <http:\/\/polioeradication.org\/news-post\/global-eradication-of-wild-poliovirus-type-2-declared\/> [accessed December 21, 2017]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/cid\/ciu1136","article-title":"Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013","volume":"60","author":"Shulman","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2807\/1560-7917.ES2013.18.38.20586","article-title":"Insidious reintroduction of wild poliovirus into Israel, 2013","volume":"18","author":"Anis","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.06.031_b0045","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S1473-3099(15)00064-X","article-title":"The Israeli public health response to wild poliovirus importation","volume":"15","author":"Kaliner","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0050","unstructured":"WHO. Detection of poliovirus in sewage, Brazil; 2014."},{"key":"10.1016\/j.vaccine.2018.06.031_b0055","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.idc.2015.07.003","article-title":"The challenge of global poliomyelitis eradication","volume":"29","author":"Garon","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2018.06.031_b0060","unstructured":"CDC. Update on vaccine-derived polioviruses \u2014 worldwide, January 2014\u2013March 2015; 2015. <http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6423a4.htm> [accessed July 14, 2016]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2015.01.018","article-title":"Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication","volume":"33","author":"Guo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.031_b0070","unstructured":"Australian Government Department of Health. The Australian immunisation handbook. Groups with special vaccination requirements; 2013. <http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/Handbook10-home~handbook10part3~handbook10-3-3#3-3-3> [accessed March 2, 2016]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ajt.12122","article-title":"Vaccination in solid organ transplantation","volume":"13","author":"Danziger-Isakov","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2018.06.031_b0080","unstructured":"Minist\u00e9rio da Sa\u00fade, Brasil. Manual dos Centros de Refer\u00eancia para Imunobiol\u00f3gicos Especiais; 2014. <http:\/\/www.saude.pr.gov.br\/arquivos\/File\/-01VACINA\/manual_crie_.pdf> [accessed March 29, 2016]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0085","unstructured":"Public Health Agency of Canada. Canadian immunization guide. Imminization of immunocompromised persons; 2014. <http:\/\/www.phac-aspc.gc.ca\/publicat\/cig-gci\/p03-07-eng.php> [accessed March 2, 2016]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0090","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0095","unstructured":"ABTO. Associa\u00e7\u00e3o Brasileira de Transplantes. Vacina\u00e7\u00e3o pr\u00e9 e p\u00f3s transplante de \u00f3rg\u00e3os em adultos; n.d. <www.abto.org.br\/download\/recomendacoes-vacinacao.docx> [accessed March 29, 2016]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00007890-199703270-00008","article-title":"Routine immunizations in adult renal transplant recipients","volume":"63","author":"Huzly","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2018.06.031_b0105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/CVI.00293-12","article-title":"High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies","volume":"19","author":"Driss","year":"2012","journal-title":"Clin Vaccine Immunol CVI"},{"key":"10.1016\/j.vaccine.2018.06.031_b0110","unstructured":"R Core Team. R: the R project for statistical computing; 2016. <https:\/\/www.r-project.org\/> [accessed November 22, 2016]."},{"key":"10.1016\/j.vaccine.2018.06.031_b0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1590\/S1413-86702002000500004","article-title":"Estimated prevalence of immunity to poliomyelitis in the city of S\u00e3o Paulo, Brazil: a population-based survey","volume":"6","author":"Kiffer","year":"2002","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0120","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2009.02.042","article-title":"Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: implications for future polio vaccination strategies","volume":"27","author":"P\u00edrez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.031_b0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-12-24","article-title":"Deficiency of immunity to poliovirus type 3: a lurking danger?","volume":"12","author":"Reinheimer","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0130","doi-asserted-by":"crossref","unstructured":"Wallace GS, Curns AT, Weldon WC, Oberste MS. Seroprevalence of poliovirus antibodies in the United States population, 2009\u20132010. BMC Public Health 2016;16. http:\/\/doi.org\/10.1186\/s12889-016-3386-1.","DOI":"10.1186\/s12889-016-3386-1"},{"key":"10.1016\/j.vaccine.2018.06.031_b0135","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/427810","article-title":"Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion","volume":"191","author":"Abbink","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0140","first-page":"175","article-title":"Boosting immune responses following fractional-dose inactivated poliovirus vaccine: a randomized, controlled trial","volume":"215","author":"Resik","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0145","series-title":"Vaccines","first-page":"573","article-title":"Poliovirus vaccine\u2014inactivated","author":"Vidor","year":"2013"},{"key":"10.1016\/j.vaccine.2018.06.031_b0150","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations","volume":"11","author":"Kumar","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2018.06.031_b0155","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2018.06.031_b0160","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/01.TP.0000438024.10375.2d","article-title":"Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients","volume":"97","author":"Cowan","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2018.06.031_b0165","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/tid.12359","article-title":"Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients","volume":"17","author":"Wyplosz","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.031_b0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yapd.2012.04.017","article-title":"Immunization in special populations","volume":"59","author":"Miller","year":"2012","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.vaccine.2018.06.031_b0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7774\/cevr.2016.5.2.125","article-title":"Vaccination strategies in patients with solid organ transplant: evidences and future perspectives","volume":"5","author":"Kim","year":"2016","journal-title":"Clin Exp Vaccine Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:53Z","timestamp":1759400873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":35,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18308594"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}